Financials
- Market Capitalization 9.74 B
- Employee 273
- Founded 2015
- CEO N/A
- Website www.kymeratx.com
- Headquarter Delaware, United States
- FIGI BBG00SDHC8D1
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-35.28
売上高対価格比率
106.17
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 909 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.23 USD | -0.51% | -1.62% | +5.87% | +97.33% | 9.95 B USD | ||
| 921 | PRAX Praxis Precision Medicines, Inc. - Common Stock | 350.99 USD | +0.20% | -4.54% | +16.64% | +678.25% | 9.80 B USD | ||
| 942 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 146.13 USD | -1.10% | -5.05% | +7.61% | +94.50% | 9.46 B USD | ||
| 959 | PCVX Vaxcyte, Inc. - Common Stock | 61.96 USD | +2.01% | -0.35% | +14.74% | +46.48% | 9.22 B USD |